Category: Q3Syndicate content

Orthofix jumps on restated financials, eNeura deal

April 1, 2015 by Mark Hollmer

Orthofix shares jump nearly 15% after the company restates its financial results back to 2011, returns to 3rd-quarter profits and inks an option-to-buy deal with eNeura.

Orthofix jumps on restated financials, eNeura deal

Synergetics pays $14m for Sterimedix

December 11, 2014 by Brad Perriello

Synergetics pays nearly $14 million to acquire U.K.-based cannulae and needles maker Sterimedix, misses expectations with fiscal 1st-quarter earnings.

Synergetics pays $14m for Sterimedix

Synergetics (NSDQ:SURG) said yesterday that it acquired a U.K.-based cannulae and needles maker, Sterimedix, for $13.5 million and announced lower-than-expected earnings for its fiscal 1st quarter.

Medtronic hits 52-week high on strong Q2 results

November 18, 2014 by Brad Perriello

Medtronic's strong fiscal 2nd-quarter results pushed its stock to a 52-week high today.

Medtronic hits 52-week high on strong Q2 results

Shares of Medtronic (NYSE:MDT) hit a 52-week high today on the strength of its 2nd-quarter results, peaking at $72.74 apiece.

MDT shares closed at $72.47 each, for a 4.7% gain on the day.

Medtronic's Q2 results meet The Street

November 18, 2014 by Brad Perriello

Medtronic reports fiscal 2nd-quarter sales and earnings in line with expectations on Wall Street.

Medtronic's Q2 results meet The Street

Medtronic (NYSE:MDT) today reported 2nd-quarter results that met expectations on Wall Street.

CareFusion's Q1 sales, earnings rise

November 7, 2014 by Brad Perriello

Sales and earnings rise during the fiscal 1st quarter for CareFusion as it prepares to be absorbed by Becton, Dickinson & Co.

CareFusion's Q1 sales, earnings rise

CareFusion (NYSE:CFN) ended its last fiscal quarter as a public company on a strong note, posting earnings growth of 2.8% on a top-line gain of 11.1%.

Wright Medical slashes losses, Q3 sales surge

November 7, 2014 by Brad Perriello

Wright Medical reports a nearly 150% reduction in 3rd-quarter losses on sales growth of 24%, but softer-than-expected sales push it to miss its earnings target by a penny.

Wright Medical slashes losses, Q3 sales surge

Insulet gains on Q3 numbers, names new CFO

November 6, 2014 by Brad Perriello

Insulet shares gain after the insulin management company turns in solid 3rd-quarter numbers and names a company insider to be its new CFO.

Insulet gains on Q3 numbers, names new CFO

Insulet (NSDQ:PODD) shares are up today after the insulin management company said its 3rd-quarter earnings topped expectations and named a new finance chief.